> top > docs > PMC:7161517 > spans > 30613-33323 > annotations

PMC:7161517 / 30613-33323 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T185 437-455 Body_part denotes Lipopolysaccharide http://purl.org/sig/ont/fma/fma82785
T186 470-474 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T187 535-539 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T188 615-620 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T189 678-682 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T190 696-700 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T191 778-796 Body_part denotes lipopolysaccharide http://purl.org/sig/ont/fma/fma82785
T192 867-874 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T193 896-900 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T194 976-980 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T195 2074-2079 Body_part denotes heart http://purl.org/sig/ont/fma/fma7088
T196 2163-2168 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T197 2182-2187 Body_part denotes Heart http://purl.org/sig/ont/fma/fma7088
T198 2390-2396 Body_part denotes tissue http://purl.org/sig/ont/fma/fma9637

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T77 470-474 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T78 535-539 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T79 678-682 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T80 696-700 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T81 896-900 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T82 938-941 Body_part denotes RAS http://purl.obolibrary.org/obo/UBERON_0018229
T83 976-980 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T84 1085-1088 Body_part denotes RAS http://purl.obolibrary.org/obo/UBERON_0018229
T85 2074-2079 Body_part denotes heart http://purl.obolibrary.org/obo/UBERON_0000948
T86 2163-2168 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T87 2182-2187 Body_part denotes Heart http://purl.obolibrary.org/obo/UBERON_0000948
T88 2289-2292 Body_part denotes RAS http://purl.obolibrary.org/obo/UBERON_0018229
T89 2390-2396 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T90 2579-2582 Body_part denotes RAS http://purl.obolibrary.org/obo/UBERON_0018229
T91 2654-2657 Body_part denotes RAS http://purl.obolibrary.org/obo/UBERON_0018229

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T162 51-59 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T163 80-88 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T164 333-351 Disease denotes SARS-CoV infection http://purl.obolibrary.org/obo/MONDO_0005091
T165 342-351 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T166 464-481 Disease denotes acute lung injury http://purl.obolibrary.org/obo/MONDO_0006502|http://purl.obolibrary.org/obo/MONDO_0015796
T168 475-481 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T169 557-563 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T170 701-707 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T171 815-821 Disease denotes injury http://purl.obolibrary.org/obo/MONDO_0021178
T172 856-864 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T173 952-960 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T174 1027-1030 Disease denotes AT1 http://purl.obolibrary.org/obo/MONDO_0008840
T175 1117-1125 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T176 1334-1342 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T177 1666-1678 Disease denotes inflammation http://purl.obolibrary.org/obo/MONDO_0021166
T178 1718-1726 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T179 1753-1775 Disease denotes cardiovascular disease http://purl.obolibrary.org/obo/MONDO_0004995
T180 1780-1788 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T181 2074-2087 Disease denotes heart failure http://purl.obolibrary.org/obo/MONDO_0005252
T182 2182-2195 Disease denotes Heart Failure http://purl.obolibrary.org/obo/MONDO_0005252
T183 2438-2446 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T184 2464-2486 Disease denotes cardiovascular disease http://purl.obolibrary.org/obo/MONDO_0004995
T185 2553-2561 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T186 2701-2709 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T289 135-143 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T290 166-167 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T291 219-224 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T292 384-386 http://purl.obolibrary.org/obo/CLO_0053799 denotes 45
T293 427-435 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T294 470-474 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T295 470-474 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T296 482-487 http://purl.obolibrary.org/obo/CLO_0007836 denotes mouse
T297 535-539 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T298 535-539 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T299 615-620 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T300 678-682 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T301 678-682 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T302 696-700 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T303 696-700 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T304 896-900 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T305 896-900 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T306 976-980 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T307 976-980 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T308 1360-1368 http://purl.obolibrary.org/obo/UBERON_0000158 denotes membrane
T309 1853-1854 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T310 1897-1898 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T311 2074-2079 http://purl.obolibrary.org/obo/UBERON_0000948 denotes heart
T312 2074-2079 http://purl.obolibrary.org/obo/UBERON_0007100 denotes heart
T313 2074-2079 http://purl.obolibrary.org/obo/UBERON_0015228 denotes heart
T314 2074-2079 http://www.ebi.ac.uk/efo/EFO_0000815 denotes heart
T315 2163-2168 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T316 2163-2168 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T317 2163-2168 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T318 2163-2168 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T319 2182-2187 http://purl.obolibrary.org/obo/UBERON_0000948 denotes Heart
T320 2182-2187 http://purl.obolibrary.org/obo/UBERON_0007100 denotes Heart
T321 2182-2187 http://purl.obolibrary.org/obo/UBERON_0015228 denotes Heart
T322 2182-2187 http://www.ebi.ac.uk/efo/EFO_0000815 denotes Heart
T323 2347-2348 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T323 168-186 Chemical denotes physiological role http://purl.obolibrary.org/obo/CHEBI_52211
T324 266-280 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T325 270-280 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T326 437-455 Chemical denotes Lipopolysaccharide http://purl.obolibrary.org/obo/CHEBI_16412|http://purl.obolibrary.org/obo/CHEBI_89981
T328 738-752 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T329 742-752 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T330 778-796 Chemical denotes lipopolysaccharide http://purl.obolibrary.org/obo/CHEBI_16412
T331 867-874 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T332 938-941 Chemical denotes RAS http://purl.obolibrary.org/obo/CHEBI_63620
T333 1085-1088 Chemical denotes RAS http://purl.obolibrary.org/obo/CHEBI_63620
T334 1803-1817 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T335 1807-1817 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T336 2289-2292 Chemical denotes RAS http://purl.obolibrary.org/obo/CHEBI_63620
T337 2293-2304 Chemical denotes antagonists http://purl.obolibrary.org/obo/CHEBI_48706
T338 2579-2582 Chemical denotes RAS http://purl.obolibrary.org/obo/CHEBI_63620
T339 2583-2593 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T340 2654-2657 Chemical denotes RAS http://purl.obolibrary.org/obo/CHEBI_63620

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T86 101-116 http://purl.obolibrary.org/obo/GO_0019068 denotes virion assembly
T87 1581-1591 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T88 1666-1678 http://purl.obolibrary.org/obo/GO_0006954 denotes inflammation

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T186 0-61 Sentence denotes Medical Management in Cardiovascular Patients With SARS-CoV-2
T187 62-225 Sentence denotes Regardless of how SARS-CoV-2 completes virion assembly, it is clear that membrane-bound ACE2 would play a physiological role in the replication of the novel virus.
T188 226-436 Sentence denotes The question remains whether the use of ACE inhibitors, ARBs, and MRAs should be avoided in the setting of SARS-CoV infection because each agent (42, 43, 44, 45, 46,53) upregulates ACE2 expression and activity.
T189 437-708 Sentence denotes Lipopolysaccharide-induced acute lung injury mouse models exhibited decreased expression of ACE2, lung and inflammatory injury; however, this was ameliorated by the injection of cells transfected with ACE2 and resulted in the improvement of lung function and lung injury.
T190 709-827 Sentence denotes Treatment of these mice with ACE inhibitors and ARBs also alleviated lipopolysaccharide-induced pneumonic injury (67).
T191 828-942 Sentence denotes Previous studies showed the SARS-CoV S protein can exaggerate acute lung failure through dysregulation of the RAS.
T192 943-1045 Sentence denotes However, SARS-CoV Spike–mediated lung failure could be rescued by inhibition of the AT1 receptor (67).
T193 1046-1330 Sentence denotes Again, adequate data on the effects of RAS inhibition in patients with COVID-19 is not available, and ongoing clinical and/or observations studies are being conducted (see previous mentions of NCT04318301, NCT04318418, NCT04312009, NCT04311177, NCT04287686, NCT04330300, NCT04329195).
T194 1331-1729 Sentence denotes If SARS-CoV-2 down-regulates membrane-bound ACE2 by promoting the ADAM17−mediated ectodomain shedding, resulting in increased concentrations of soluble ACE2 without compromising viral propagation, we hypothesize this would result in the overall down regulation of the ACE2/Ang1-7/Mas pathway, which would contribute to the severity of inflammation and systemic dysregulation observed in SARS-CoV-2.
T195 1730-2088 Sentence denotes Thus, in patients with cardiovascular disease and SARS-CoV-2, the use of ACE inhibitors, ARBs, or MRAs may be favorable as a method to endogenously upregulate ACE2 as a compensatory mechanism that provides anti-inflammatory, antifibrotic, and antithrombotic support as well as reduction in progression of vascular and/or cardiac remodeling and heart failure.
T196 2089-2487 Sentence denotes Several societies, including the American College of Cardiology, American Heart Association, Heart Failure Society of America (68), and European Society of Cardiology (69) have recommended continuing RAS antagonists because of the lack of conclusive data on a link between upregulation of systemic or tissue ACE2 and the increased susceptibility to COVID-19 in patients with cardiovascular disease.
T197 2488-2710 Sentence denotes Based on our review, we hypothesize cardiovascular patients with COVID-19 should remain on RAS inhibitors because of the protective effects of the ACE2 pathway until RAS blockade is proven to increase the risk of COVID-19.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T48 464-481 Phenotype denotes acute lung injury http://www.orpha.net/ORDO/Orphanet_178320
T49 1753-1775 Phenotype denotes cardiovascular disease http://purl.obolibrary.org/obo/HP_0001626
T50 2074-2087 Phenotype denotes heart failure http://purl.obolibrary.org/obo/HP_0001635
T51 2182-2195 Phenotype denotes Heart Failure http://purl.obolibrary.org/obo/HP_0001635
T52 2464-2486 Phenotype denotes cardiovascular disease http://purl.obolibrary.org/obo/HP_0001626

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T1000 22-36 UBERON:0004535 denotes Cardiovascular
T1001 51-61 SP_7 denotes SARS-CoV-2
T1002 80-90 SP_7 denotes SARS-CoV-2
T1003 101-116 GO:0019068 denotes virion assembly
T1004 135-143 GO:0016020 denotes membrane
T1005 150-154 G_3;PG_10;PR:000003622 denotes ACE2
T1006 194-205 GO:0006260 denotes replication
T1007 219-224 NCBITaxon:10239 denotes virus
T1008 270-280 CHEBI:35222;CHEBI:35222 denotes inhibitors
T1009 333-341 SP_10 denotes SARS-CoV
T1010 407-411 G_3;PG_10;PR:000003622 denotes ACE2
T1011 412-422 GO:0010467 denotes expression
T1012 437-455 CHEBI:16412;CHEBI:16412 denotes Lipopolysaccharide
T1013 470-474 UBERON:0002048 denotes lung
T1014 482-487 NCBITaxon:10088 denotes mouse
T1015 515-525 GO:0010467 denotes expression
T1016 529-533 G_3;PG_10;PR:000003622 denotes ACE2
T1017 535-539 UBERON:0002048 denotes lung
T1018 621-632 GO:0009294 denotes transfected
T1019 638-642 G_3;PG_10;PR:000003622 denotes ACE2
T1020 678-682 UBERON:0002048 denotes lung
T1021 696-700 UBERON:0002048 denotes lung
T1022 728-732 NCBITaxon:10088 denotes mice
T1023 742-752 CHEBI:35222;CHEBI:35222 denotes inhibitors
T1024 778-796 CHEBI:16412;CHEBI:16412 denotes lipopolysaccharide
T1025 805-814 UBERON:0006562 denotes pneumonic
T1026 856-864 SP_10 denotes SARS-CoV
T1027 865-874 PG_1 denotes S protein
T1028 896-900 UBERON:0002048 denotes lung
T1029 917-930 GO:0065007 denotes dysregulation
T1030 952-960 SP_10 denotes SARS-CoV
T1031 976-980 UBERON:0002048 denotes lung
T1032 1027-1030 PR:000001251 denotes AT1
T1033 1117-1125 SP_7 denotes COVID-19
T1034 1334-1344 SP_7 denotes SARS-CoV-2
T1035 1360-1368 GO:0016020 denotes membrane
T1036 1375-1379 G_3;PG_10;PR:000003622 denotes ACE2
T1037 1397-1403 PR:000001279 denotes ADAM17
T1038 1483-1487 G_3;PG_10;PR:000003622 denotes ACE2
T1039 1509-1514 NCBITaxon:10239 denotes viral
T1040 1599-1603 G_3;PG_10;PR:000003622 denotes ACE2
T1041 1604-1608 PR:000036013 denotes Ang1
T1042 1611-1614 PR:000001563 denotes Mas
T1043 1692-1705 GO:0065007 denotes dysregulation
T1044 1718-1728 SP_7 denotes SARS-CoV-2
T1045 1753-1767 UBERON:0004535 denotes cardiovascular
T1046 1780-1790 SP_7 denotes SARS-CoV-2
T1047 1807-1817 CHEBI:35222;CHEBI:35222 denotes inhibitors
T1048 1889-1893 G_3;PG_10;PR:000003622 denotes ACE2
T1049 2051-2058 UBERON:0000948 denotes cardiac
T1050 2074-2079 UBERON:0000948 denotes heart
T1051 2142-2152 UBERON:0000948 denotes Cardiology
T1052 2163-2168 UBERON:0000948 denotes Heart
T1053 2182-2187 UBERON:0000948 denotes Heart
T1054 2245-2255 UBERON:0000948 denotes Cardiology
T1055 2390-2396 UBERON:0000479 denotes tissue
T1056 2397-2401 G_3;PG_10;PR:000003622 denotes ACE2
T1057 2438-2446 SP_7 denotes COVID-19
T1058 2464-2478 UBERON:0004535 denotes cardiovascular
T1059 2524-2538 UBERON:0004535 denotes cardiovascular
T1060 2553-2561 SP_7 denotes COVID-19
T1061 2583-2593 CHEBI:35222;CHEBI:35222 denotes inhibitors
T1062 2635-2639 G_3;PG_10;PR:000003622 denotes ACE2
T1063 2701-2709 SP_7 denotes COVID-19
T49 1599-1603 G_3;PG_10;PR:000003622 denotes ACE2
T50 1604-1608 PR:000036013 denotes Ang1
T51 1807-1817 CHEBI:35222;CHEBI:35222 denotes inhibitors
T56 2464-2478 UBERON:0004535 denotes cardiovascular
T42119 2553-2561 SP_7 denotes COVID-19
T94149 22-36 UBERON:0004535 denotes Cardiovascular
T11413 51-61 SP_7 denotes SARS-CoV-2
T96807 80-90 SP_7 denotes SARS-CoV-2
T29852 101-116 GO:0019068 denotes virion assembly
T92838 135-143 GO:0016020 denotes membrane
T55000 150-154 G_3;PG_10;PR:000003622 denotes ACE2
T37615 194-205 GO:0006260 denotes replication
T3663 219-224 NCBITaxon:10239 denotes virus
T77253 270-280 CHEBI:35222;CHEBI:35222 denotes inhibitors
T68013 333-341 SP_10 denotes SARS-CoV
T90735 407-411 G_3;PG_10;PR:000003622 denotes ACE2
T99855 412-422 GO:0010467 denotes expression
T45949 437-455 CHEBI:16412;CHEBI:16412 denotes Lipopolysaccharide
T26573 470-474 UBERON:0002048 denotes lung
T67408 482-487 NCBITaxon:10088 denotes mouse
T64221 515-525 GO:0010467 denotes expression
T339 529-533 G_3;PG_10;PR:000003622 denotes ACE2
T57577 535-539 UBERON:0002048 denotes lung
T30771 621-632 GO:0009294 denotes transfected
T2102 638-642 G_3;PG_10;PR:000003622 denotes ACE2
T26427 678-682 UBERON:0002048 denotes lung
T88548 696-700 UBERON:0002048 denotes lung
T40701 728-732 NCBITaxon:10088 denotes mice
T25934 742-752 CHEBI:35222;CHEBI:35222 denotes inhibitors
T13796 778-796 CHEBI:16412;CHEBI:16412 denotes lipopolysaccharide
T57031 805-814 UBERON:0006562 denotes pneumonic
T56145 856-864 SP_10 denotes SARS-CoV
T3099 865-874 PG_1 denotes S protein
T33336 896-900 UBERON:0002048 denotes lung
T48754 917-930 GO:0065007 denotes dysregulation
T39370 952-960 SP_10 denotes SARS-CoV
T41763 976-980 UBERON:0002048 denotes lung
T35901 1027-1030 PR:000001251 denotes AT1
T86863 1117-1125 SP_7 denotes COVID-19
T90528 1334-1344 SP_7 denotes SARS-CoV-2
T82967 1360-1368 GO:0016020 denotes membrane
T4860 1375-1379 G_3;PG_10;PR:000003622 denotes ACE2
T49764 1397-1403 PR:000001279 denotes ADAM17
T57158 1483-1487 G_3;PG_10;PR:000003622 denotes ACE2
T51582 1509-1514 NCBITaxon:10239 denotes viral
T18657 1599-1603 G_3;PG_10;PR:000003622 denotes ACE2
T56429 1604-1608 PR:000036013 denotes Ang1
T24733 1611-1614 PR:000001563 denotes Mas
T40354 1692-1705 GO:0065007 denotes dysregulation
T61569 1718-1728 SP_7 denotes SARS-CoV-2
T7547 1753-1767 UBERON:0004535 denotes cardiovascular
T55968 1780-1790 SP_7 denotes SARS-CoV-2
T80913 1807-1817 CHEBI:35222;CHEBI:35222 denotes inhibitors
T91618 1889-1893 G_3;PG_10;PR:000003622 denotes ACE2
T66182 2051-2058 UBERON:0000948 denotes cardiac
T49783 2074-2079 UBERON:0000948 denotes heart
T17759 2142-2152 UBERON:0000948 denotes Cardiology
T7351 2163-2168 UBERON:0000948 denotes Heart
T73963 2182-2187 UBERON:0000948 denotes Heart
T87034 2245-2255 UBERON:0000948 denotes Cardiology
T40873 2390-2396 UBERON:0000479 denotes tissue
T70153 2397-2401 G_3;PG_10;PR:000003622 denotes ACE2
T30590 2438-2446 SP_7 denotes COVID-19
T5335 2464-2478 UBERON:0004535 denotes cardiovascular
T24575 2524-2538 UBERON:0004535 denotes cardiovascular
T78530 2553-2561 SP_7 denotes COVID-19
T40154 2583-2593 CHEBI:35222;CHEBI:35222 denotes inhibitors
T60460 2635-2639 G_3;PG_10;PR:000003622 denotes ACE2
T33728 2701-2709 SP_7 denotes COVID-19

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1289 37-45 Species denotes Patients Tax:9606
1295 150-154 Gene denotes ACE2 Gene:59272
1296 266-269 Gene denotes ACE Gene:1636
1297 407-411 Gene denotes ACE2 Gene:59272
1298 80-90 Species denotes SARS-CoV-2 Tax:2697049
1299 333-351 Disease denotes SARS-CoV infection MESH:C000657245
1316 529-533 Gene denotes ACE2 Gene:70008
1317 638-642 Gene denotes ACE2 Gene:70008
1318 738-741 Gene denotes ACE Gene:11421
1319 482-487 Species denotes mouse Tax:10090
1320 728-732 Species denotes mice Tax:10090
1321 856-864 Species denotes SARS-CoV Tax:694009
1322 952-960 Species denotes SARS-CoV Tax:694009
1323 1103-1111 Species denotes patients Tax:9606
1324 437-455 Chemical denotes Lipopolysaccharide MESH:D008070
1325 778-796 Chemical denotes lipopolysaccharide MESH:D008070
1326 464-481 Disease denotes acute lung injury MESH:D055371
1327 696-707 Disease denotes lung injury MESH:D055370
1328 805-821 Disease denotes pneumonic injury MESH:D011014
1329 896-908 Disease denotes lung failure MESH:D012131
1330 976-988 Disease denotes lung failure MESH:D012131
1331 1117-1125 Disease denotes COVID-19 MESH:C000657245
1354 1375-1379 Gene denotes ACE2 Gene:59272
1355 1397-1403 Gene denotes ADAM17 Gene:6868
1356 1483-1487 Gene denotes ACE2 Gene:59272
1357 1599-1603 Gene denotes ACE2 Gene:59272
1358 1604-1610 Gene denotes Ang1-7 Gene:284
1359 1803-1806 Gene denotes ACE Gene:1636
1360 1889-1893 Gene denotes ACE2 Gene:59272
1361 2397-2401 Gene denotes ACE2 Gene:59272
1362 2635-2639 Gene denotes ACE2 Gene:59272
1363 1334-1344 Species denotes SARS-CoV-2 Tax:2697049
1364 1718-1728 Species denotes SARS-CoV-2 Tax:2697049
1365 1739-1747 Species denotes patients Tax:9606
1366 1780-1790 Species denotes SARS-CoV-2 Tax:2697049
1367 2450-2458 Species denotes patients Tax:9606
1368 2539-2547 Species denotes patients Tax:9606
1369 1666-1678 Disease denotes inflammation MESH:D007249
1370 1753-1775 Disease denotes cardiovascular disease MESH:D002318
1371 2074-2087 Disease denotes heart failure MESH:D006333
1372 2438-2446 Disease denotes COVID-19 MESH:C000657245
1373 2464-2486 Disease denotes cardiovascular disease MESH:D002318
1374 2553-2561 Disease denotes COVID-19 MESH:C000657245
1375 2701-2709 Disease denotes COVID-19 MESH:C000657245

2_test

Id Subject Object Predicate Lexical cue
32305401-16179584-55252999 372-374 16179584 denotes 42
32305401-15159288-55253000 376-378 15159288 denotes 43
32305401-15833808-55253001 380-382 15833808 denotes 44
32305401-27085217-55253002 384-386 27085217 denotes 45
32305401-15007027-55253003 388-390 15007027 denotes 46
32305401-9461243-55253004 391-393 9461243 denotes 53
32305401-31805278-55253005 823-825 31805278 denotes 67
32305401-31805278-55253006 1041-1043 31805278 denotes 67